Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Margolin

Showing results (321-330 of 406) with videos related to

Pageof 41
Sort By:
Acta Neuropathologica Communications|November 8, 2019
Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer's diseaseChristopher D Whelan, Niklas Mattsson, Michael W Nagle, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 1, 2007
Phase I/II trial of outpatient PEG-interferon with interleukin-2 in advanced renal cell carcinoma: a cytokine working group studyJoseph I Clark, Jessica Mehrabi, Jeffrey A Sosman, et al.
Research Square|February 24, 2023
An open protocol for modeling T Cell Clonotype repertoires using TCRβ CDR3 sequencesBurcu Gurun, Wesley Horton, Dhaarini Murugan, et al.
BMC Genomics|June 26, 2023
An open protocol for modeling T Cell Clonotype repertoires using TCRβ CDR3 sequencesBurcu Gurun, Wesley Horton, Dhaarini Murugan, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 2018
Pan-cancer transcriptional signatures predictive of oncogenic mutations reveal that Fbw7 regulates cancer cell oxidative metabolismRyan J Davis, Mehmet Gönen, Daciana H Margineantu, et al.
Cancer Chemotherapy and Pharmacology|July 27, 2000
Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosisM L Tetef, K A Margolin, J H Doroshow, et al.
BMC Bioinformatics|September 27, 2018
Valection: design optimization for validation and verification studiesChristopher I Cooper, Delia Yao, Dorota H Sendorek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2014
Functional kinomics identifies candidate therapeutic targets in head and neck cancerRussell Moser, Chang Xu, Michael Kao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Sixteen-week multidrug regimen versus cyclophosphamide, doxorubicin, and fluorouracil as adjuvant therapy for node-positive, receptor-negative breast cancer: an Intergroup studyJ H Fetting, R Gray, D L Fairclough, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2010
Prognostic factors in patients with metastatic germ cell tumors who experienced treatment failure with cisplatin-based first-line chemotherapy, Anja Lorch, Jörg Beyer, et al.
Pageof 41

Showing results (321-330 of 406) with videos related to

Sort By:
Pageof 41
Acta Neuropathologica Communications|November 8, 2019
Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer's diseaseChristopher D Whelan, Niklas Mattsson, Michael W Nagle, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 1, 2007
Phase I/II trial of outpatient PEG-interferon with interleukin-2 in advanced renal cell carcinoma: a cytokine working group studyJoseph I Clark, Jessica Mehrabi, Jeffrey A Sosman, et al.
Research Square|February 24, 2023
An open protocol for modeling T Cell Clonotype repertoires using TCRβ CDR3 sequencesBurcu Gurun, Wesley Horton, Dhaarini Murugan, et al.
BMC Genomics|June 26, 2023
An open protocol for modeling T Cell Clonotype repertoires using TCRβ CDR3 sequencesBurcu Gurun, Wesley Horton, Dhaarini Murugan, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 2018
Pan-cancer transcriptional signatures predictive of oncogenic mutations reveal that Fbw7 regulates cancer cell oxidative metabolismRyan J Davis, Mehmet Gönen, Daciana H Margineantu, et al.
Cancer Chemotherapy and Pharmacology|July 27, 2000
Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosisM L Tetef, K A Margolin, J H Doroshow, et al.
BMC Bioinformatics|September 27, 2018
Valection: design optimization for validation and verification studiesChristopher I Cooper, Delia Yao, Dorota H Sendorek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2014
Functional kinomics identifies candidate therapeutic targets in head and neck cancerRussell Moser, Chang Xu, Michael Kao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Sixteen-week multidrug regimen versus cyclophosphamide, doxorubicin, and fluorouracil as adjuvant therapy for node-positive, receptor-negative breast cancer: an Intergroup studyJ H Fetting, R Gray, D L Fairclough, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2010
Prognostic factors in patients with metastatic germ cell tumors who experienced treatment failure with cisplatin-based first-line chemotherapy, Anja Lorch, Jörg Beyer, et al.
Pageof 41